Medical Developments International | MVP - Fremdkapital





Fremdkapital Veränderung Datum
Akebia Therapeutics USD 24.75M 11.64M 2026-06
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Clinuvel Pharmaceuticals AUD 17.25K 80.1K 2025-12
Dianthus Therapeutics USD 0 0 2024-12
Genetic Signatures AUD 94K 258K 2025-12
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Medical Developments International AUD 1.5M 167K 2025-12
Organon & Co USD 8.48B 74M 2026-06
PYC Therapeutics AUD 436.93K 188.06K 2025-12
Starpharma Holdings AUD 1.14M 410K 2025-06
Tectonic Therapeutic USD 17K 26K 2026-03
Telix Pharmaceuticals AUD 564.44M 115.99M 2026-06
Viatris USD 11.61B 801.1M 2026-06
Xeris Pharmaceuticals USD 188.81M 32.42M 2026-06